{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:24:40Z","timestamp":1792553080031,"version":"4.5.0"},"reference-count":178,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>\n                    African trypanosomiasis is associated with\n                    <jats:italic>Trypanosoma evansi, T. vivax, T. congolense<\/jats:italic>\n                    , and\n                    <jats:italic>T. brucei<\/jats:italic>\n                    pathogens in African animal trypanosomiasis (AAT) while\n                    <jats:italic>T. b gambiense<\/jats:italic>\n                    and\n                    <jats:italic>T. b rhodesiense<\/jats:italic>\n                    are responsible for chronic and acute human African trypanosomiasis (HAT), respectively. Suramin sodium suppresses ATP generation during the glycolytic pathway and is ineffective against\n                    <jats:italic>T. vivax<\/jats:italic>\n                    and\n                    <jats:italic>T. congolense<\/jats:italic>\n                    infections. Resistance to suramin is associated with pathogen altered transport proteins. Melarsoprol binds irreversibly with pyruvate kinase protein sulfhydryl groups and neutralizes enzymes which interrupts the trypanosome ATP generation. Melarsoprol resistance is associated with the adenine-adenosine transporter, P2, due to point mutations within this transporter. Eflornithine is used in combination with nifurtimox. Resistance to eflornithine is caused by the deletion or mutation of TbAAT6 gene which encodes the transmembrane amino acid transporter that delivers eflornithine into the cell, thus loss of transporter protein results in eflornithine resistance. Nifurtimox alone is regarded as a poor trypanocide, however, it is effective in melarsoprol-resistant gHAT patients. Resistance is associated with loss of a single copy of the genes encoding for nitroreductase enzymes. Fexinidazole is recommended for first-stage and non-severe second-stage illnesses in gHAT and resistance is associated with trypanosome bacterial nitroreductases which reduce fexinidazole. In AAT, quinapyramine sulfate interferes with DNA synthesis and suppression of cytoplasmic ribosomal activity in the mitochondria. Quinapyramine sulfate resistance is due to variations in the potential of the parasite's mitochondrial membrane. Pentamidines create cross-links between two adenines at 4\u20135 pairs apart in adenine-thymine-rich portions of\n                    <jats:italic>Trypanosoma<\/jats:italic>\n                    DNA. It also suppresses type II topoisomerase in the mitochondria of\n                    <jats:italic>Trypanosoma<\/jats:italic>\n                    parasites. Pentamidine resistance is due to loss of mitochondria transport proteins P2 and HAPT1. Diamidines are most effective against\n                    <jats:italic>Trypanosome brucei<\/jats:italic>\n                    group and act\n                    <jats:italic>via<\/jats:italic>\n                    the P2\/TbAT1 transporters. Diminazene aceturate resistance is due to mutations that alter the activity of P2, TeDR40 (\n                    <jats:italic>T. b. evansi<\/jats:italic>\n                    ). Isometamidium chloride is primarily employed in the early stages of trypanosomiasis and resistance is associated with diminazene resistance. Phenanthridine (homidium bromide, also known as ethidium bromide) acts by a breakdown of the kinetoplast network and homidium resistance is comparable to isometamidium. In humans, the development of resistance and adverse side effects against monotherapies has led to the adoption of nifurtimox-eflornithine combination therapy. Current efforts to develop new prodrug combinations of nifurtimox and eflornithine and nitroimidazole fexinidazole as well as benzoxaborole SCYX-7158 (AN5568) for HAT are in progress while little comparable progress has been done for the development of novel therapies to address trypanocide resistance in AAT.\n                  <\/jats:p>","DOI":"10.3389\/fvets.2022.828111","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T01:47:29Z","timestamp":1646617649000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":91,"title":["An Update on African Trypanocide Pharmaceutics and Resistance"],"prefix":"10.3389","volume":"9","author":[{"given":"Keneth Iceland","family":"Kasozi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan Thomas","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Ntulume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Christina","family":"Welburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1454","DOI":"10.1371\/journal.pntd.0001454","article-title":"High prevalence of drug resistance in animal trypanosomes without a history of drug exposure","volume":"5","author":"Chitanga","year":"2011","journal-title":"PLoS Negl Trop Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"621699","DOI":"10.3389\/fvets.2021.621699","article-title":"Epidemiology of trypanosomiasis in wildlife\u2014implications for humans at the wildlife interface in Africa","volume":"8","author":"Kasozi","year":"2021","journal-title":"Front Vet Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1017\/S0031182016001268","article-title":"The animal trypanosomiases and their chemotherapy : a review","volume":"143","author":"Giordani","year":"2016","journal-title":"Parasitology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s13346-020-00764-x","article-title":"Nanotechnological interventions for treatment of trypanosomiasis in humans and animals","volume":"10","author":"Prayag","year":"2020","journal-title":"Drug Deliv Transl Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.actatropica.2017.08.032","article-title":"Animal African trypanosomiasis in nigeria: a long way from elimination\/eradication","volume":"176","author":"Isaac","year":"2017","journal-title":"Acta Tropica."},{"key":"B6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.actatropica.2015.03.014","article-title":"In vivo experimental drug resistance study in Trypanosoma vivax isolates from tsetse infested and non-tsetse infested areas of Northwest Ethiopia","volume":"146","author":"Dagnachew","year":"2015","journal-title":"Acta Tropica."},{"key":"B7","first-page":"581","article-title":"Cattle anaemia and trypanosomiasis in western Oromia State, Ethiopia","volume":"163","author":"Tasew","year":"2012","journal-title":"Revue M\u00e9d V\u00e9t"},{"key":"B8","doi-asserted-by":"publisher","first-page":"611141","DOI":"10.3389\/fvets.2021.611141","article-title":"critical linkages between livestock production, livestock trade and potential spread of human african trypanosomiasis in uganda: bioeconomic herd modeling and livestock trade analysis","volume":"8","author":"Okello","year":"2021","journal-title":"Front Vet Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"100309","DOI":"10.1016\/j.vprsr.2019.100309","article-title":"Prevalence of hemoprotozoan parasites in small ruminants along a human-livestock-wildlife interface in western Uganda","volume":"17","author":"Kasozi","year":"2019","journal-title":"Vet Parasitol Reg Stud Rep."},{"key":"B10","unstructured":"Trypanosomiasis, Human African (Sleeping Sickness)2020"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0008261","DOI":"10.1371\/journal.pntd.0008261","article-title":"Monitoring the elimination of human African trypanosomiasis at continental and country level: update to 2018","volume":"14","author":"Franco","year":"2020","journal-title":"PLoS Negl Trop Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.actatropica.2016.08.022","article-title":"Impact of mass chemotherapy in domestic livestock for control of zoonotic T. b. rhodesiense human African trypanosomiasis in Eastern Uganda","volume":"165","author":"Fyfe","year":"2017","journal-title":"Acta Tropica."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/ismej.2014.236","article-title":"Adult blood-feeding tsetse flies, trypanosomes, microbiota and the fluctuating environment in sub-Saharan Africa","volume":"9","author":"Geiger","year":"2015","journal-title":"ISME J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1051\/parasite\/2013026","article-title":"Transmission of pathogens by stomoxys flies (diptera, muscidae): a review","volume":"20","author":"Baldacchino","year":"2013","journal-title":"Parasite"},{"key":"B15","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1128\/MMBR.00024-10","article-title":"Cell biology of the trypanosome genome","volume":"74","author":"Daniels","year":"2010","journal-title":"Microbiol Mol Biol Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1073\/pnas.1117313109","article-title":"Antigenic diversity is generated by distinct evolutionary mechanisms in African trypanosome species","volume":"109","author":"Jackson","year":"2012","journal-title":"Proc Natl Acad Sci USA."},{"key":"B17","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1126\/science.1112642","article-title":"The genome of the african trypanosome Trypanosoma brucei","volume":"309","author":"Berriman","year":"2005","journal-title":"Science"},{"key":"B18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.molbiopara.2010.11.004","article-title":"The VSG C-terminal domain is inaccessible to antibodies on live trypanosomes","volume":"175","author":"Schwede","year":"2011","journal-title":"Mol Biochem Parasitol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1126\/science.276.5312.611","article-title":"Partitioning of large and minichromosomes in Trypanosoma brucei","volume":"276","author":"Ersfeld","year":"1997","journal-title":"Science"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1126\/science.aaa4502","article-title":"The in vivo dynamics of antigenic variation in Trypanosoma brucei","volume":"347","author":"Mugnier","year":"2015","journal-title":"Science"},{"key":"B21","doi-asserted-by":"publisher","first-page":"130023","DOI":"10.1098\/rsob.130023","article-title":"Evolutionary cell biology of chromosome segregation: Insights from trypanosomes","volume":"3","author":"Akiyoshi","year":"2013","journal-title":"Open Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.molbiopara.2014.05.001","article-title":"Molecular & biochemical parasitology antigenic variation in african trypanosomes","volume":"195","author":"Horn","year":"2014","journal-title":"Mol Biochem Parasitol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e3527","DOI":"10.1371\/journal.pone.0003527","article-title":"Telomeric expression sites are highly conserved in Trypanosoma brucei","volume":"3","author":"Hertz-Fowler","year":"2008","journal-title":"PLoS ONE"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e658","DOI":"10.1371\/journal.pntd.0000658","article-title":"The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human African trypanosomiasis","volume":"4","author":"Jackson","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1186\/gb-2007-8-3-r37","article-title":"Repetitive DNA is associated with centromeric domains in Trypanosoma brucei but not Trypanosoma cruzi","volume":"8","author":"Obado","year":"2007","journal-title":"Genome Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/nar\/gkq839","article-title":"Centromere-associated topoisomerase activity in bloodstream form Trypanosoma brucei","volume":"39","author":"Obado","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1046\/j.1365-2958.2003.03266.x","article-title":"The identification of circular extrachromosomal DNA in the nuclear genome of Trypanosoma brucei","volume":"47","author":"Alsford","year":"2003","journal-title":"Mol Microbiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1101\/gr.2227704","article-title":"The small chromosomes of Trypanosoma brucei involved in antigenic variation are constructed around repetitive palindromes","volume":"14","author":"Wickstead","year":"2004","journal-title":"Genome Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e25313","DOI":"10.1371\/journal.pone.0025313","article-title":"Identification of Trypanosoma brucei RMI1\/BLAP75 homologue and its roles in antigenic variation","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS ONE."},{"key":"B30","doi-asserted-by":"publisher","first-page":"7757","DOI":"10.1093\/nar\/gky597","article-title":"Trypanosoma bruceiUMSBP2 is a single-stranded telomeric DNA binding protein essential for chromosome end protection","volume":"46","author":"Klebanov-Akopyan","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molbiopara.2007.01.017","article-title":"Cell cycle regulation in Trypanosoma brucei. Mol Biochem Parasitol","volume":"153","author":"Hammarton","year":"2007"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1128\/EC.00145-12","article-title":"Regulation of the cell division cycle in Trypanosoma brucei","volume":"11","author":"Li","year":"2012","journal-title":"Eukaryotic Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"17599","DOI":"10.1038\/s41598-017-17779-z","article-title":"Cell cycle synchronisation of Trypanosoma brucei by centrifugal counter-flow elutriation reveals the timing of nuclear and kinetoplast DNA replication","volume":"7","author":"Benz","year":"2017","journal-title":"Sci Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S.0074-02762008000100001","article-title":"Trypanosoma (Duttonella) vivax: its biology, epidemiology, pathogenesis, and introduction in the new world - a review","volume":"103","author":"Os\u00f3rio","year":"2008","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e1976","DOI":"10.1371\/journal.pntd.0001976","article-title":"Non-Invasive in vivo study of the Trypanosoma vivax infectious process consolidates the brain commitment in late infections","volume":"7","author":"D'Archivio","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.20506\/rst.34.2.2382","article-title":"Cattle trypanosomosis: the diversity of trypanosomes and implications for disease epidemiology and control","volume":"34","author":"Auty","year":"2015","journal-title":"Rev Sci Tech."},{"key":"B37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.meegid.2014.01.012","article-title":"Congopain genes diverged to become specific to savannah, forest and kilifi subgroups of Trypanosoma congolense, and are valuable for diagnosis, genotyping and phylogenetic inferences","volume":"23","author":"Rodrigues","year":"2014","journal-title":"Infect Genet Evol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1756-3305-5-109","article-title":"The life cycle of trypanosoma (nannomonas) congolense in the tsetse fly","volume":"5","author":"Peacock","year":"2012","journal-title":"Parasit Vectors."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.3389\/fimmu.2018.02253","article-title":"Salivarian trypanosomosis: a review of parasites involved, their global distribution and their interaction with the innate and adaptive mammalian host immune system","volume":"9","author":"Radwanska","year":"2018","journal-title":"Front Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1046\/j.1365-2915.1998.00131.x","article-title":"Mechanical transmission of Trypanosoma evansi and T. congolense by Stomoxys niger and S. taeniatus in a laboratory mouse model","volume":"12","author":"Sumba","year":"1998","journal-title":"Med Vet Entomol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0304-4173(76)90011-2","article-title":"Electron transport systems in kinetoplastida","volume":"456","author":"Hill","year":"1976","journal-title":"Biochim Biophys Acta."},{"key":"B42","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3389\/fchem.2020.00696","article-title":"Targeting L-proline uptake as new strategy for anti-chagas drug development","volume":"8","author":"Fargnoli","year":"2020","journal-title":"Front Chem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0009323","DOI":"10.1371\/journal.pntd.0009323","article-title":"Diversity of trypanosomes in humans and cattle in the HAT foci mandoul and maro, Southern Chad \u2014 a matter of concern for zoonotic potential?","volume":"15","author":"Alhadj","year":"2021","journal-title":"PLoS Negl Trop Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2307\/3275663","article-title":"A review of electron transport mechanisms in parasitic protozoa","volume":"49","author":"Baernstein","year":"1963","journal-title":"J Parasitol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e1009734","DOI":"10.1371\/journal.ppat.1009734","article-title":"Divergent metabolism between Trypanosoma congolense and Trypanosoma brucei results in differential sensitivity to metabolic inhibition","volume":"17","author":"Steketee","year":"2021","journal-title":"PLoS Pathog."},{"key":"B46","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/mmi.12979","article-title":"Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein","volume":"96","author":"Munday","year":"2015","journal-title":"Mol Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1756-3305-6-322","article-title":"Domestic pigs as potential reservoirs of human and animal trypanosomiasis in Northern Tanzania","volume":"6","author":"Hamill","year":"2013","journal-title":"Parasit Vect."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.14202\/vetworld.2020.2502-2507","article-title":"Frequency and diversity of trypanosomes in sheep and goats from Mongo County in South Gabon, Central Africa","volume":"13","author":"Maganga","year":"2020","journal-title":"Vet World."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0003353","DOI":"10.1371\/journal.pntd.0003353","article-title":"Genetic diversity and population structure of Trypanosoma brucei in Uganda: implications for the epidemiology of sleeping sickness and nagana","volume":"9","author":"Echodu","year":"2015","journal-title":"PLOS Negl Trop Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e0004645","DOI":"10.1371\/journal.pntd.0004645","article-title":"Correction: murine models for Trypanosoma brucei gambiense disease progression\u2014from silent to chronic infections and early brain tropism","volume":"10","author":"Giroud","year":"2016","journal-title":"PLOS Negl Trop Dis."},{"key":"B51","doi-asserted-by":"publisher","first-page":"194176","DOI":"10.1155\/2013\/194176","article-title":"Trypanosoma evansi and surra: a review and perspectives on origin, history, distribution, taxonomy, morphology, hosts, pathogenic effects","volume":"2013","author":"Desquesnes","year":"2013","journal-title":"BioMed Res Int."},{"key":"B52","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.vetpar.2014.12.027","article-title":"Trypanosoma from rodents as potential source of infection in human-shaped landscapes of South-East Asia","volume":"208","author":"Pumhom","year":"2015","journal-title":"Vet Parasitol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1093\/cid\/ciw052","article-title":"A clinical and epidemiological investigation of the first reported human infection with the zoonotic parasite Trypanosoma evansi in Southeast Asia","volume":"62","author":"Van Vinh Chau","year":"2016","journal-title":"Clin Infect Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e2256","DOI":"10.1371\/journal.pntd.0002256","article-title":"Atypical human infections by animal trypanosomes","volume":"7","author":"Truc","year":"2013","journal-title":"PLoS Negl Trop Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.pt.2005.05.010","article-title":"Trypanosoma equiperdum: master of disguise or historical mistake?","volume":"21","author":"Claes","year":"2005","journal-title":"Trends Parasitol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.vetpar.2012.12.006","article-title":"Diagnosis of dourine in outbreaks in Italy","volume":"193","author":"Pascucci","year":"2013","journal-title":"Vet Parasitol."},{"key":"B57","doi-asserted-by":"crossref","first-page":"361368","DOI":"10.1016\/0001-706X(89)90048-X","article-title":"In vitro drug sensitivity test for Trypanosoma brucei subgroup bloodstream trypomastigotes","volume":"46","author":"Brun","year":"1989","journal-title":"Acta Tropica"},{"key":"B58","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.vetpar.2010.03.041","article-title":"Efficacy of cymelarsan and diminasan against Trypanosoma equiperdum infections in mice and horses","volume":"4","author":"Hagos","year":"2010","journal-title":"Vet Parasitol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"14741","DOI":"10.1073\/pnas.1305404110","article-title":"Single point mutations in ATP synthase compensate for mitochondrial genome loss in trypanosomes","volume":"110","author":"Dean","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B60","unstructured":"Centers for Disease Control. African Trypanosomiasis. DPDx - Laboratory Identification of Parasites of Public Health Concern2020"},{"key":"B61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/pathogens6030029","article-title":"The cytological events and molecular control of life cycle development of Trypanosoma brucei in the mammalian bloodstream","volume":"6","author":"Silvester","year":"2017","journal-title":"Pathogens."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.1371\/journal.pmed.0050055","article-title":"Eliminating human African trypanosomiasis: where do we stand and what comes next?","volume":"5","author":"Simarro","year":"2008","journal-title":"PLoS Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0065-308X(01)49038-5","article-title":"The epidemiology and control of human African trypanosomiasis","volume":"49","author":"P\u00e9pin","year":"2001","journal-title":"Adv Parasitol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"634","DOI":"10.3201\/eid0806.010432","article-title":"Cluster of African trypanosomiasis in travelers to Tanzanian national parks","volume":"8","author":"Jelinek","year":"2002","journal-title":"Emerg Infect Dis."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e1003502","DOI":"10.1371\/journal.ppat.1003502","article-title":"Mosaic VSGs and the scale of Trypanosoma brucei antigenic variation","volume":"9","author":"Hall","year":"2013","journal-title":"PLoS Pathog."},{"key":"B66","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.vetpar.2014.04.002","article-title":"The susceptibility of Trypanosoma congolense and Trypanosoma brucei to isometamidium chloride and its synthetic impurities","volume":"203","author":"Sahin","year":"2014","journal-title":"Vet Parasitol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1016\/S0140-6736(17)31510-6","article-title":"Human African trypanosomiasis","volume":"390","author":"B\u00fcscher","year":"2017","journal-title":"Lancet."},{"key":"B68","unstructured":"GenevaWorld Health OrganizationControl and Surveillance of Human African Trypanosomiasis: Report of a WHO Expert Committee2013"},{"key":"B69","unstructured":"GenevaWorld Health OrganizationWHO Interim Guidelines for the Treatment of Gambiense Human African Trypanosomiasis2019"},{"key":"B70","unstructured":"Pentamidine\n            HafizS\n            KyriakopoulosC\n          Treasure Island, FStatPearls PublishingStatPearls2022"},{"key":"B71","unstructured":"Trypanosomiasis, Human African (Sleeping Sickness)2021"},{"key":"B72","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1007\/s00436-002-0752-y","article-title":"Current chemotherapy of human African trypanosomiasis","volume":"90","author":"Docampo","year":"2003","journal-title":"Parasitol Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S0035-9203(96)90533-7","article-title":"Metronidazole and suramin combination in the treatment of arsenical refractory rhodesian sleeping sickness - a case study","volume":"90","author":"Foulkes","year":"1996","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B74","doi-asserted-by":"publisher","first-page":"C157","DOI":"10.12968\/hmed.2016.77.10.C157","article-title":"African sleeping sickness","volume":"77","author":"Hedley","year":"2016","journal-title":"Br J Hosp Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.3390\/molecules26154629","article-title":"An overview on target-based drug design against kinetoplastid protozoan infections: human African trypanosomiasis, chagas disease and leishmaniases","volume":"26","author":"Kourbeli","year":"2021","journal-title":"Molecules."},{"key":"B76","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s00436-002-0799-9","article-title":"Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis","volume":"90","author":"Nok","year":"2003","journal-title":"Parasitol Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"e01168","DOI":"10.1128\/AAC.01168-19","article-title":"100 years of suramin","volume":"64","author":"Wiedemar","year":"2020","journal-title":"Antimicrobiol Agents Chemother."},{"key":"B78","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0140-6736(04)16940-7","article-title":"fficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness","volume":"364","author":"Schmid","year":"2004","journal-title":"Lancet."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1086\/429929","article-title":"Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II)","volume":"191","author":"Schmid","year":"2005","journal-title":"J Infect Dis."},{"key":"B80","doi-asserted-by":"publisher","first-page":"e1695","DOI":"10.1371\/journal.pntd.0001695","article-title":"Safety and efficacy of the 10-day melarsoprol schedule for the treatment of second stage rhodesiense sleeping sickness","volume":"6","author":"Kuepfer","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma bruceigambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet."},{"key":"B82","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2471\/BLT.06.031955","article-title":"Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of Congo","volume":"84","author":"Balasegaram","year":"2006","journal-title":"Bull World Health Organ."},{"key":"B83","doi-asserted-by":"publisher","first-page":"100182","DOI":"10.1016\/j.onehlt.2020.100182","article-title":"Sleeping hearts: 12 years after a follow up study on cardiac findings due to sleeping sickness","volume":"11","author":"Blum","year":"2020","journal-title":"One Health."},{"key":"B84","doi-asserted-by":"publisher","first-page":"CD015374","DOI":"10.1002\/14651858.CD006201.pub3","article-title":"Chemotherapy for second-stage human african trypanosomiasis","volume":"12","author":"Lutje","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"B85","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.exppara.2015.01.016","article-title":"Evaluation of trypanocidal activity of combinations of anti-sleeping sickness drugs with cysteine protease inhibitors","volume":"2","author":"Steverding","year":"2015","journal-title":"Exp Parasitol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.exppara.2017.05.006","article-title":"Front-line glioblastoma chemotherapeutic temozolomide is toxic to Trypanosoma brucei and potently enhances melarsoprol and eflornithine","volume":"178","author":"Steverding","year":"2017","journal-title":"Exp Parasitol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e16881","DOI":"10.7759\/cureus.16881","article-title":"Efficacy and toxicity of fexinidazole and nifurtimox plus eflornithine in the treatment of African trypanosomiasis","volume":"13","author":"Hidalgo","year":"2021","journal-title":"Cureus."},{"key":"B88","doi-asserted-by":"publisher","first-page":"655435","DOI":"10.3389\/fmolb.2021.655435","article-title":"Nano-Medicines a hope for chagas disease! Frontiers Mol Biosci","volume":"8","author":"Choudhury","year":"2021"},{"key":"B89","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13071-018-2634-x","article-title":"A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda","volume":"11","author":"Kansiime","year":"2018","journal-title":"Parasit Vect."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e1920","DOI":"10.1371\/journal.pntd.0001920","article-title":"In-Hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness","volume":"6","author":"Schmid","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e720","DOI":"10.1371\/journal.pntd.0000720","article-title":"NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness","volume":"4","author":"Yun","year":"2010","journal-title":"PLoS Negl Trop Dis."},{"key":"B92","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1128\/AAC.00246-11","article-title":"Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness","volume":"55","author":"Kaiser","year":"2011","journal-title":"Antimicrobiol Agents Chemother."},{"key":"B93","doi-asserted-by":"publisher","first-page":"e923","DOI":"10.1371\/journal.pntd.0000923","article-title":"Fexinidazole\u2013a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness","volume":"4","author":"Torreele","year":"2010","journal-title":"PLoS Negl Trop Dis."},{"key":"B94","unstructured":"Fexinidazole Dosing, Indications, Interactions, Adverse Effects, and MoreMedscape2021"},{"key":"B95","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S0140-6736(17)32758-7","article-title":"Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial","volume":"391","author":"Mesu","year":"2018","journal-title":"Lancet."},{"key":"B96","unstructured":"Diseases: Neglected Tropical Diseases. Centers for Disease Control on Nov 202020"},{"key":"B97","unstructured":"GenevaWorld Health OrganizationNeglected Tropical Diseases: Sleeping Sickness (Human African Trypanosomiasis)2020"},{"key":"B98","doi-asserted-by":"publisher","first-page":"69","DOI":"10.5334\/gh.891","article-title":"COVID-19: implications for people with chagas disease","volume":"15","author":"Zaidel","year":"2020","journal-title":"Global Heart."},{"key":"B99","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.idc.2018.10.015","article-title":"American trypanosomiasis (chagas disease)","volume":"33","author":"Echeverria","year":"2019","journal-title":"Infect Dis Clin N Am."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.amjmed.2020.05.022","article-title":"Chagas disease: epidemiology and barriers to treatment","volume":"133","author":"Mills","year":"2020","journal-title":"Am J Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e13429","DOI":"10.1111\/tid.13429","article-title":"American trypanosomiasis (Chagas disease) in solid organ transplantation","volume":"22","author":"Radisic","year":"2020","journal-title":"Transplant Infect Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1358\/dot.2019.55.11.3068795","article-title":"Fexinidazole for the treatment of human African trypanosomiasis","volume":"55","author":"Fairlamb","year":"2019","journal-title":"Drugs Today."},{"key":"B103","doi-asserted-by":"publisher","first-page":"e999","DOI":"10.1016\/S2214-109X(21)00208-4","article-title":"Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study","volume":"9","author":"Kande Betu Ku Mesu","year":"2021","journal-title":"Lancet Glob Health."},{"key":"B104","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0001-706X(93)90096-T","article-title":"The uptake of the trypanocidal drug suramin in combination with low-density lipoproteins by Trypanosoma brucei and its possible mode of action","volume":"54","author":"Vansterkenburg","year":"1993","journal-title":"Acta Tropica."},{"key":"B105","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0166-6851(80)90050-X","article-title":"Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma bruceia nd its effect on respiration and growth rate in vivo","volume":"1","author":"Fairlamb","year":"1980","journal-title":"Mol Biochem Parasitol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature10771","article-title":"High-throughput decoding of antitrypanosomal drug efficacy and resistance","volume":"482","author":"Alsford","year":"2012","journal-title":"Nature."},{"key":"B107","unstructured":"Chemotherapy of protozoal infections: Amebiasis, Giardiasis, Trichomoniasis, Trypanosomiasis, Leishmaniasis, and Other Protozoal Infections\n            WetzelDM\n            PhillipsMA\n          \n            BruntonLL\n          Goodman and Gilman's: The Pharmacological Basis of Therapeutics2017"},{"key":"B108","doi-asserted-by":"publisher","first-page":"E1001204","DOI":"10.1371\/journal.ppat.1001204","article-title":"A molecular mechanism for eflornithine resistance in African trypanosomes","volume":"6","author":"Vincent","year":"2010","journal-title":"PLoS Pathog."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.2217\/fmb.11.88","article-title":"Drug resistance in human African trypanosomiasis","volume":"6","author":"Barrett","year":"2011","journal-title":"Fut Microbiol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/jac\/dkv376","article-title":"Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei","volume":"2015","author":"Wyllie","year":"2016","journal-title":"J Antimicrobiol Chemother"},{"key":"B111","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"key":"B112","doi-asserted-by":"publisher","first-page":"e02515","DOI":"10.1128\/AAC.02515-18","article-title":"Pharmacokinetic-Pharmacodynamic assessment of the hepatic and bone marrow toxicities of the new trypanoside fexinidazole","volume":"63","author":"Watson","year":"2019","journal-title":"Antimicrobiol Agents Chemother."},{"key":"B113","volume-title":"Foye's Principles of Medicinal Chemistry. 7th edn.","author":"Lemke","year":"2013"},{"key":"B114","doi-asserted-by":"publisher","first-page":"e0006890","DOI":"10.1371\/journal.pntd.0006890","article-title":"Monitoring the elimination of human African trypanosomiasis: Update to 2016","volume":"12","author":"Franco","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"B115","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/CLEP.S39728","article-title":"Epidemiology of human African trypanosomiasis","volume":"6","author":"Franco","year":"2014","journal-title":"Clin Epidemiol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"20160172","DOI":"10.1098\/rstb.2016.0172","article-title":"Engaging research with policy and action: what are the challenges of responding to zoonotic disease in Africa?","volume":"372","author":"Bardosh","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B117","doi-asserted-by":"publisher","first-page":"e0005792","DOI":"10.1371\/journal.pntd.0005792","article-title":"Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the mandoul focus (Chad)","volume":"11","author":"Mahamat","year":"2017","journal-title":"PLOS Negl Trop Dis."},{"key":"B118","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pt.2015.11.008","article-title":"beyond tsetse - implications for research and control of human african trypanosomiasis epidemics","volume":"32","author":"Welburn","year":"2016","journal-title":"Trends Parasitol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12917-018-1633-7","article-title":"Drug quality analysis of isometamidium chloride hydrochloride and diminazene diaceturate used for the treatment of African animal trypanosomosis in West Africa","volume":"14","author":"Bengaly","year":"2018","journal-title":"BMC Vet Res."},{"key":"B120","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4102\/ojvr.v86i1.1639","article-title":"African animal trypanosomosis (nagana) in northern KwaZulu-Natal, South Africa: strategic treatment of cattle on a farm in endemic area","volume":"86","author":"Latif","year":"2019","journal-title":"Onderstepoort J Vet Res."},{"key":"B121","doi-asserted-by":"publisher","first-page":"e0006980","DOI":"10.1371\/journal.pntd.0006980","article-title":"Insights into antitrypanosomal drug mode-of-action from cytology-based profiling","volume":"12","author":"Thomas","year":"2018","journal-title":"PLOS Negl Trop Dis."},{"key":"B122","doi-asserted-by":"publisher","first-page":"102905","DOI":"10.1016\/j.jevs.2019.102905","article-title":"Treatment efficiency of combination therapy with diminazene aceturate and quinapyramine sulfate in a horse with dourine","volume":"87","author":"Davkharbayar","year":"2020","journal-title":"J Equine Vet Sci."},{"key":"B123","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1590\/s1984-29612019018","article-title":"Clinical and therapeutic aspects of an outbreak of canine trypanosomiasis","volume":"28","author":"Echeverria","year":"2019","journal-title":"Rev Bras Parasitol Vet."},{"key":"B124","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.xphs.2021.01.033","article-title":"Preparation and evaluation of quinapyramine sulphate-docusate sodium ionic complex loaded lipidic nanoparticles and its scale up using geometric similarity principle","volume":"110","author":"Prayag","year":"2021","journal-title":"J Pharm Sci."},{"key":"B125","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s11250-017-1239-2","article-title":"Trypanosomiasis challenge estimation using the diminazene aceturate (Berenil) index in Zebu in Gabon","volume":"49","author":"Cossic","year":"2017","journal-title":"Trop Anim Health Prod."},{"key":"B126","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13071-021-04584-x","article-title":"Global distribution, host range and prevalence of Trypanosoma vivax: a systematic review and meta-analysis","volume":"14","author":"Fetene","year":"2021","journal-title":"Parasit Vect."},{"key":"B127","first-page":"239","article-title":"Berenil (diminazene aceturate)-resistant Trypanosoma congolense in cattle under natural tsetse challenge at Kibaha, Tanzania","volume":"45","author":"Mbwambo","year":"1988","journal-title":"Acta Tropica."},{"key":"B128","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0001-706X(93)90092-P","article-title":"Pharmacology of diminazene: a review","volume":"54","author":"Peregrine","year":"1993","journal-title":"Acta Tropica."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1292\/jvms.19-0043","article-title":"Melarsomine suppresses canine osteosarcoma cell survival via inhibition of Hedgehog-GLI signaling","volume":"81","author":"ArYung","year":"2019","journal-title":"J Vet Med Sci."},{"key":"B130","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.vetpar.2018.11.005","article-title":"Melarsomine hydrochloride (Cymelarsan\u00ae) fails to cure horses with Trypanosoma equiperdum OVI parasites in their cerebrospinal fluid","volume":"264","author":"H\u00e9bert","year":"2018","journal-title":"Vet Parasitol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"e0007175","DOI":"10.1371\/journal.pntd.0007175","article-title":"Safety and efficacy of three trypanocides in confirmed field cases of trypanosomiasis in working equines in the Gambia: a prospective, randomised, non-inferiority trial","volume":"13","author":"Raftery","year":"2019","journal-title":"PLOS Negl Trop Dis."},{"key":"B132","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1186\/s13071-018-3264-z","article-title":"Efficacy and side effects of doxycycline versus minocycline in the three-dose melarsomine canine adulticidal heartworm treatment protocol","volume":"11","author":"Savadelis","year":"2018","journal-title":"Parasit Vect."},{"key":"B133","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3109\/10520290903297528","article-title":"Dyes, trypanosomiasis and DNA: a historical and critical review","volume":"85","author":"Wainwright","year":"2010","journal-title":"Biotech Histochem."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1128\/AAC.41.7.1604","article-title":"Cross-resistance associated with development of resistance to isometamidium in a clone of Trypanosoma congolense","volume":"41","author":"Peregrine","year":"1997","journal-title":"Antimicrobiol Agents Chemother"},{"key":"B135","doi-asserted-by":"crossref","first-page":"950954","DOI":"10.1073\/pnas.87.3.950","article-title":"Selective cleavage of kinetoplast DNA minicircles promoted by antitrypanosomal drugs","volume":"87","author":"Shapiro","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"B136","doi-asserted-by":"publisher","first-page":"e1001226","DOI":"10.1371\/journal.ppat.1001226","article-title":"The killing of African trypanosomes by ethidium bromide","volume":"6","author":"Chowdhury","year":"2010","journal-title":"PLoS Pathog."},{"key":"B137","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0001-706X(94)00080-K","article-title":"Comparison of isometamidium chloride and homidium bromide as prophylactic drugs for trypanosomiasis in cattle at Nguruman, Kenya","volume":"59","author":"Stevenson","year":"1995","journal-title":"Acta Tropica."},{"key":"B138","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0301-4622(82)87014-2","article-title":"The interaction between prothidium dibromide and DNA at the molecular level","volume":"15","author":"Dougherty","year":"1982","journal-title":"Biophys Chem."},{"key":"B139","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1476-5381.1950.tb00573.x","article-title":"Antrycide, a new trypanocidal drug","volume":"5","author":"Curd","year":"1950","journal-title":"Br J Pharmacol Chemother."},{"key":"B140","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1128\/AAC.00122-14","article-title":"Independence from Kinetoplast DNA maintenance and expression is associated with multidrug resistance in Trypanosoma brucei in vitro","volume":"58","author":"Gould","year":"2014","journal-title":"Antimicrobiol Agents Chemother"},{"key":"B141","doi-asserted-by":"publisher","first-page":"e48696","DOI":"10.1371\/journal.pone.0048696","article-title":"Diminazene aceturate (Berenil) modulates the host cellular and inflammatory responses to Trypanosoma congolense infection","volume":"7","author":"Kuriakose","year":"2012","journal-title":"PLoS ONE."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1128\/AAC.48.5.1515-1519.2004","article-title":"The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in African trypanosomes","volume":"48","author":"Koning","year":"2004","journal-title":"Antimicrobiaol Agents Chemother."},{"key":"B143","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/jac\/dkt442","article-title":"Trypanosoma bruceiaquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs","volume":"69","author":"Munday","year":"2014","journal-title":"J Antimicrobiol Chemother."},{"key":"B144","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.drup.2008.10.002","article-title":"Five-fold increase in Trypanosoma congolense isolates resistant to diminazene aceturate over a seven-year period in Eastern Zambia","volume":"11","author":"Delespaux","year":"2008","journal-title":"Drug Resist Updates."},{"key":"B145","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/tropicalmed5010014","article-title":"The drugs of sleeping sickness: their mechanisms of action and resistance, and a brief history","volume":"5","author":"De Koning","year":"2020","journal-title":"Trop Med Infect Dis."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: pharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br J Pharmacol."},{"key":"B147","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1021\/acsinfecdis.0c00105","article-title":"Structure\u2013Activity relationship exploration of 3\u2032-deoxy-7-deazapurine nucleoside analogues as anti-Trypanosoma brucei agents","volume":"6","author":"Hulpia","year":"2020","journal-title":"ACS Infect Dis."},{"key":"B148","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fphar.2015.00032","article-title":"Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei","volume":"6","author":"Munday","year":"2015","journal-title":"Front Pharmacol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"e1005236","DOI":"10.1371\/journal.ppat.1005236","article-title":"Modulation of the surface proteome through multiple ubiquitylation pathways in african trypanosomes","volume":"11","author":"Zoltner","year":"2015","journal-title":"PLOS Pathog."},{"key":"B150","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijpddr.2013.01.004","article-title":"Functional expression of TcoAT1 reveals it to be a P1-type nucleoside transporter with no capacity for diminazene uptake","volume":"3","author":"Munday","year":"2013","journal-title":"Int J Parasitol Drugs Drug Resist."},{"key":"B151","doi-asserted-by":"publisher","first-page":"e0008458","DOI":"10.1371\/journal.pntd.0008458","article-title":"Instability of aquaglyceroporin (AQP) 2 contributes to drug resistance in Trypanosoma brucei","volume":"14","author":"Quintana","year":"2020","journal-title":"PLOS Negl Trop Dis"},{"key":"B152","doi-asserted-by":"publisher","first-page":"100566","DOI":"10.1016\/j.jbc.2021.100566","article-title":"Nutrient availability regulates proline\/alanine transporters in Trypanosoma brucei","volume":"296","author":"Haindrich","year":"2021","journal-title":"J Biol Chem"},{"key":"B153","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.molbiopara.2018.12.006","article-title":"Protean permeases: diverse roles for membrane transport proteins in kinetoplastid protozoa","volume":"227","author":"Landfear","year":"2019","journal-title":"Mol Biochem Parasitol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1042\/BJ20140719","article-title":"Trypanosoma bruceieflornithine transporter AAT6 is a low-affinity low-selective transporter for neutral amino acids","volume":"463","author":"Mathieu","year":"2014","journal-title":"Biochem J."},{"key":"B155","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0304-4017(99)00156-9","article-title":"Development of a decision support system for trypanocidal drug control of bovine trypanosomosis in Africa","volume":"87","author":"Gu","year":"1999","journal-title":"Vet Parasitol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/cid\/cis886","article-title":"Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: m\u00e9decins sans fronti\u00e8res experience in the democratic republic of the Congo","volume":"56","author":"Alirol","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B157","doi-asserted-by":"publisher","first-page":"4658","DOI":"10.2174\/1381612826666200331091853","article-title":"Recent advances in the synthesis and development of nitroaromatics as anti-infective drugs","volume":"26","author":"Kannigadu","year":"2020","journal-title":"Curr Pharmaceut Des."},{"key":"B158","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/B978-0-12-398457-9.00004-4","article-title":"Priorities for the elimination of sleeping sickness","volume":"79","author":"Welburn","year":"2012","journal-title":"Adv Parasitol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/978-0-387-77570-8_3","article-title":"Drugs and transporters in kinetoplastid protozoa","volume":"625","author":"Scott","year":"2008","journal-title":"Adv Exp Med Biol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1017\/S003118200500836X","article-title":"Acquired resistance to berenil in a cloned isolate of Trypanosoma evansi is associated with upregulation of a novel gene, TeDR40","volume":"131","author":"Witola","year":"2005","journal-title":"Parasitology."},{"key":"B161","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.actatropica.2006.10.001","article-title":"SSCP analysis of the P2 purine transporter TcoAT1 gene of Trypanosoma congolense leads to a simple PCR-RFLP test allowing the rapid identification of diminazene resistant stocks","volume":"100","author":"Delespaux","year":"2006","journal-title":"Acta Tropica."},{"key":"B162","doi-asserted-by":"publisher","first-page":"11518","DOI":"10.1016\/j.actatropica.2008.02.003","article-title":"Assessment of the occurrence of trypanocidal drug resistance in trypanosomes of naturally infected cattle in the Adamaoua region of Cameroon using the standard mouse test and molecular tools","volume":"106","author":"Mamoudou","year":"2008","journal-title":"Acta Tropica."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0304-4017(94)00780-G","article-title":"Resistance to diminazine aceturate by Trypanosoma congolense from cattle in the Zambezi Valley of Zimbabwe","volume":"60","author":"Joshua","year":"1995","journal-title":"Vet Parasitol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1042\/bj3260755","article-title":"Modulation of mitochondrial electrical potential: a candidate mechanism for drug resistance in African trypanosomes","volume":"326","author":"Wilkes","year":"1997","journal-title":"Biochem J."},{"key":"B165","article-title":"The diagnosis, treatment and prevention of animal trypanosomiasis under field conditions","volume-title":"Programme for the Control of African Animal Trypanosomiasis and Related Development: Ecological and Technical Aspects","author":"Connor","year":"1992"},{"key":"B166","doi-asserted-by":"crossref","first-page":"101110","DOI":"10.1016\/0001-706X(91)90002-2","article-title":"In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium","volume":"50","author":"Zhang","year":"1991","journal-title":"Acta Tropica"},{"key":"B167","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0001-706X(94)90013-2","article-title":"Induction of resistance to melarsenoxide cysteamine (Mel Cy) in Trypanosoma brucei brucei","volume":"58","author":"Pospichal","year":"1994","journal-title":"Acta Tropica."},{"key":"B168","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.pt.2008.04.006","article-title":"Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes","volume":"24","author":"Koning De","year":"2018","journal-title":"Trends Parasitol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"e92028","DOI":"10.1371\/journal.pone.0092028","article-title":"Proline modulates the Trypanosoma cruzi resistance to reactive oxygen species and drugs through a novel D. L-proline transporter","volume":"9","author":"Say\u00e9","year":"2014","journal-title":"PLoS ONE."},{"key":"B170","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1179\/2047773213Y.0000000105","article-title":"A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasis","volume":"107","author":"Babokhov","year":"2013","journal-title":"Pathog Glob Health"},{"key":"B171","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.pt.2018.08.006","article-title":"The long wait for a new drug for human african trypanosomiasis","volume":"34","author":"Baker","year":"2018","journal-title":"Trends Parasitol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/mutage\/ges015","article-title":"Genotoxicity profile of fexinidazole - a drug candidate in clinical development for human African trypanomiasis (sleeping sickness)","volume":"27","author":"Tweats","year":"2012","journal-title":"Mutagenesis"},{"key":"B173","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1016\/j.bmcl.2011.05.009","article-title":"Synthesis and structure-activity relationships of nitrobenzyl phosphoramide mustards as nitroreductase-activated prodrugs","volume":"21","author":"Hu","year":"2011","journal-title":"Bioorgan Med Chem Lett"},{"key":"B174","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.mrgentox.2004.02.013","article-title":"In vitro and in vivo chromosomal aberrations induced by megazol","volume":"560","author":"Nesslany","year":"2004","journal-title":"Mutat Res."},{"key":"B175","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cub.2013.11.044","article-title":"Meiosis and haploid gametes in the pathogen Trypanosoma brucei","volume":"24","author":"Peacock","year":"2014","journal-title":"Curr Biol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nature12516","article-title":"Mechanism of Trypanosoma brucei gambiense resistance to human serum","volume":"501","author":"Uzureau","year":"2013","journal-title":"Nature"},{"key":"B177","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.coph.2012.05.001","article-title":"Antiparasitic agents: new drugs on the horizon","volume":"12","author":"M\u00e4ser","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/tmi.12483","article-title":"Contemporary and emerging strategies for eliminating human African trypanosomiasis due to Trypanosoma brucei gambiense: review","volume":"20","author":"Steinmann","year":"2015","journal-title":"Trop Med Int Health."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.828111\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T06:23:58Z","timestamp":1646720638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2022.828111\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":178,"alternative-id":["10.3389\/fvets.2022.828111"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2022.828111","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"article-number":"828111"}}